Comparing Alpha Cognition (NASDAQ:ACOG) and Vireo Growth (OTCMKTS:VREOD)
by Sarita Garza · The Markets DailyAlpha Cognition (NASDAQ:ACOG – Get Free Report) and Vireo Growth (OTCMKTS:VREOD – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, analyst recommendations, profitability, dividends and valuation.
Risk & Volatility
Alpha Cognition has a beta of 2.32, indicating that its stock price is 132% more volatile than the S&P 500. Comparatively, Vireo Growth has a beta of 1.78, indicating that its stock price is 78% more volatile than the S&P 500.
Profitability
This table compares Alpha Cognition and Vireo Growth’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Alpha Cognition | -153.61% | -54.60% | -43.47% |
| Vireo Growth | -23.37% | -19.76% | -7.15% |
Earnings & Valuation
This table compares Alpha Cognition and Vireo Growth”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Alpha Cognition | $10.22 million | 18.97 | -$20.67 million | ($1.10) | -8.09 |
| Vireo Growth | $268.77 million | 1.68 | -$68.11 million | ($3.30) | -3.02 |
Alpha Cognition has higher earnings, but lower revenue than Vireo Growth. Alpha Cognition is trading at a lower price-to-earnings ratio than Vireo Growth, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of current recommendations and price targets for Alpha Cognition and Vireo Growth, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Alpha Cognition | 0 | 0 | 5 | 0 | 3.00 |
| Vireo Growth | 1 | 0 | 0 | 0 | 1.00 |
Alpha Cognition currently has a consensus price target of $18.00, indicating a potential upside of 102.25%. Given Alpha Cognition’s stronger consensus rating and higher probable upside, research analysts plainly believe Alpha Cognition is more favorable than Vireo Growth.
Summary
Alpha Cognition beats Vireo Growth on 7 of the 12 factors compared between the two stocks.
About Alpha Cognition
Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.
About Vireo Growth
Goodness Growth Holdings, Inc. operates as a cannabis company in the United States. The company cultivates, processes, and distributes medical and adult-use cannabis products. It sells cannabis products through its network of Green Goods and other Goodness Growth branded retail dispensaries and third-party dispensaries in Maryland, Minnesota, and New York. The company was formerly known as Vireo Health International Inc. and changed its name to Goodness Growth Holdings, Inc. in June 2021. Goodness Growth Holdings, Inc. is headquartered in Minneapolis, Minnesota.